Washington Cancer Center

Washington D.C., District of Columbia 20010

1 studies enrolling now · 2 studies all time

What they study most

Clear Cell Renal Carcinoma, Metastatic HER2-positive Breast Cancer

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• TroVax Renal Immunotherapy Survival Trial — Completed